Methods for preventing or reducing neurotoxicity associated with administering DPD inhibitors in combination with 5-FU and 5-FU prodrugs
    3.
    发明授权
    Methods for preventing or reducing neurotoxicity associated with administering DPD inhibitors in combination with 5-FU and 5-FU prodrugs 有权
    与5-FU和5-FU前药组合施用DPD抑制剂相关的预防或减少神经毒性的方法

    公开(公告)号:US08658618B2

    公开(公告)日:2014-02-25

    申请号:US12904974

    申请日:2010-10-14

    申请人: Thomas Spector

    发明人: Thomas Spector

    IPC分类号: A61K31/70 A61K31/505

    CPC分类号: A61K31/513 A61K2300/00

    摘要: Methods for improved administration and dosing of DPD inhibitors in combination with 5-FU and/or 5-FU prodrugs are provided, comprising first administering to a patient in need thereof a DPD inhibitor that substantially eliminates activity of the enzyme in both nervous and non-nervous tissues within the patient and thereafter administering 5-FU or a 5-FU prodrug, wherein the level of 5-FU or 5-FU generated from a prodrug is in substantial excess of DPD inhibitor in the patient.

    摘要翻译: 提供了用于改进DPD抑制剂与5-FU和/或5-FU前药组合的给药和给药方法,包括首先向有需要的患者施用DPD抑制剂,其基本上消除了神经和非 - 患者内的神经组织,然后施用5-FU或5-FU前药,其中由前药产生的5-FU或5-FU的水平在患者体内显着超过DPD抑制剂。

    METHODS FOR PREVENTING OR REDUCING NEUROTOXICITY ASSOCIATED WITH ADMINISTERING DPD INHIBITORS IN COMBINATION WITH 5-FU AND 5-FU PRODRUGS
    4.
    发明申请
    METHODS FOR PREVENTING OR REDUCING NEUROTOXICITY ASSOCIATED WITH ADMINISTERING DPD INHIBITORS IN COMBINATION WITH 5-FU AND 5-FU PRODRUGS 有权
    与5-FU和5-FU PRODRUGS组合联合使用DPD抑制剂预防或降低神经毒性的方法

    公开(公告)号:US20110130359A1

    公开(公告)日:2011-06-02

    申请号:US12904974

    申请日:2010-10-14

    申请人: Thomas Spector

    发明人: Thomas Spector

    CPC分类号: A61K31/513 A61K2300/00

    摘要: Methods for improved administration and dosing of DPD inhibitors in combination with 5-FU and/or 5-FU prodrugs are provided, comprising first administering to a patient in need thereof a DPD inhibitor that substantially eliminates activity of the enzyme in both nervous and non-nervous tissues within the patient and thereafter administering 5-FU or a 5-FU prodrug, wherein the level of 5-FU or 5-FU generated from a prodrug is in substantial excess of DPD inhibitor in the patient.

    摘要翻译: 提供了用于改进DPD抑制剂与5-FU和/或5-FU前药组合的给药和给药方法,包括首先向有需要的患者施用DPD抑制剂,其基本上消除了神经和非 - 患者内的神经组织,然后施用5-FU或5-FU前药,其中由前药产生的5-FU或5-FU的水平在患者体内显着超过DPD抑制剂。